Lung Cancer Clinical Trials in Dallas, TX

Lung Cancer Clinical Trials in Dallas, TX

View the best 10 lung cancer medical studies in Dallas, Texas. Access promising new therapies by applying to a Dallas-based Lung Cancer clinical trial.

Top rated lung cancer clinical trials in Dallas, Texas

Here are the top 10 medical studies for lung cancer in Dallas, Texas

Image of Washington University School of Medicine, Siteman Cancer Center in Saint Louis, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial will test a drug (CTX-471) alone or with pembrolizumab to treat cancer that has not responded to PD-1/PD-L1 inhibitor drugs. Two parts of the trial will assess different doses.
Image of Banner MD Anderson Cancer Center in Gilbert, United States.

RGX-104

Small Molecule

Recruiting3 awardsPhase 1
This trial is testing a new drug, RGX-104, to see if it is safe and effective when used alone or with other drugs to treat different types of cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Hypofractionated Radiation Therapy

Radiation

Recruiting1 awardPhase 2
This trial is testing the safety and effectiveness of a new cancer treatment that involves radiation therapy followed by immunotherapy with atezolizumab.
Image of Alabama Oncology - Grandview in Birmingham, United States.

Sitravatinib +2 More

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of sitravatinib when given with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression after platinum-based chemotherapy and checkpoint inhibitor therapy.
Image of GSK Investigational Site in Lone Tree, United States.

Pembrolizumab

Recruiting1 awardPhase 3
This trial is testing if adding niraparib to pembrolizumab maintenance therapy could improve progression-free survival and overall survival in participants with advanced or metastatic non-small cell lung cancer who have achieved stable disease, partial response, or complete response following completion of standard of care first-line platinum-based induction chemotherapy with pembrolizumab.
Image of University of Alabama at Birmingham Comprehensive Cancer Center in Birmingham, United States.

NovoTTF-200M device

Device

Recruiting2 awardsPhase 3
This trial tests a device to treat brain metastases in advanced NSCLC patients, comparing it to the current standard of care.
Image of Research Site in Chandler, United States.

Durvalumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new cancer treatment (durvalumab with SoC SBRT) against the current best treatment (placebo with SoC SBRT) for early stage non-small cell lung cancer.
Image of California Pacific Medical Center in San Francisco, United States.

Nivolumab +6 More

Checkpoint Inhibitor

Recruiting2 awardsPhase 3
This trial is testing whether Nivolumab, or a combination of Nivolumab and Ipilimumab, or Nivolumab and Platinum-Doublet Chemotherapy can help people with advanced lung cancer live longer without their disease getting worse, or improve overall survival.
Image of Medical Oncology Associates in Spokane, United States.

Zimberelimab +4 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will measure the effectiveness of a combination of drugs to fight cancer and how safe they are.
Image of Cancer Centers of Florida in Ocoee, United States.

Recombinant DNA and Adenovirus Expressing L523S Protein

Cancer Vaccine

Recruiting1 awardPhase 1
This trial is testing a new vaccine for early stage non-small cell lung cancer. The vaccine consists of two doses of recombinant DNA, followed by two doses of recombinant adenovirus. The trial will evaluate the safety and effectiveness of the vaccine.

Popular filter options for lung-cancer dallas trials

Phase 3 Clinical Trials

View 94 phase 3 medical studies.

Clinical Trials With No Placebo

View 94 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.